Here's some additional history about Anavex and Dr. Missling's contributions to the company.
When Dr. Missling came aboard in 2013 the SP was about $1/share and the company was on the brink of bankruptcy. Below is the auditor's comments:
"The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1 to the consolidated financial statements, the Company had an accumulated deficit of $41,204,972 and negative working capital of $1,559,211 at September 30, 2013 and incurred a net loss of $3,700,046 for the year then ended.These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter."
Once they hired Dr. Missling in 2013, he successfully executed a plan to turn the company around.
Since then, the SP has increased 800%...now at $8/share...they have $150 MM in the bank and no longer in debt...the employment growth has exploded in preparation for the commercialization of their new drug, Blarcamesine. (See below)
News 
Market Data 
Discover 
